Healthcare Infection Control Practices Advisory Committee, (HICPAC), 55567 [E9-25913]

Download as PDF Federal Register / Vol. 74, No. 207 / Wednesday, October 28, 2009 / Notices 52968. The time, place, and public comment period of the ACD, CDC—HDS meeting has changed. The meeting will also be teleconferenced. Time: 2 p.m.–3:30 p.m. Place: CDC, 1600 Clifton Road, NE., Atlanta, GA 30333, Building 19, Room 247/ 248, Global Communication Center. To participate by teleconference, please dial 1– 800–369–2112 and enter passcode 4102105. Status: Open to the public; teleconference access limited only by availability of telephone ports. The public is welcome to participate during the public comments period which is tentatively scheduled from 3 to 3:15 p.m. EDT. Contact Person for More Information: Walter W. Williams, M.D., M.P.H., Designated Federal Officer, ACD, CDC—HDS, 1600 Clifton Road, NE., M/S E67, Atlanta, Georgia 30333. Telephone 404–498–2310, Email: www1@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: October 22, 2009. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–26054 Filed 10–27–09; 8:45 am] 55567 Agenda: To review and evaluate grant applications. Place: Nat’l Institute of Environmental Health Sciences, 530 Davis Drive, Morrisville, NC 27560 (Telephone Conference Call). Contact Person: Teresa Nesbitt, PhD, DVM, Chief, Scientific Review Branch, Division of Extramural Research and Training, Nat’l Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709, (919) 541–7571, nesbittt@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Matters To Be Discussed: The agenda will include updates on Recovery Act activities and the draft guideline for prevention of intravascular catheter-related bloodstream infections, and discussion of infection control in ambulatory care settings. Agenda items are subject to change as priorities dictate. Contact Person For More Information: Michelle King, HICPAC, Division of Healthcare Quality Promotion, NCPDCID, CDC, l600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333 Telephone (404) 639– 2936. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 20, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Dated: October 22, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25995 Filed 10–27–09; 8:45 am] [FR Doc. E9–25913 Filed 10–27–09; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) National Cancer Institute; Notice of Closed Meeting BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Healthcare Infection Control Practices Advisory Committee, (HICPAC) National Institutes of Health In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. erowe on DSK5CLS3C1PROD with NOTICES National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Conference Grant Review With An Environmental Health Focus. Date: November 20, 2009. Time: 1 p.m. to 3:30 p.m. VerDate Nov<24>2008 15:34 Oct 27, 2009 Jkt 220001 Times and Dates: 9 a.m.–5 p.m., November 12, 2009. 9 a.m.–12 p.m., November 13, 2009. Place: Washington Marriott at Metro Center, Salons C–D, 775 12th Street, NW., Washington, DC 20005, Telephone: (202) 737–2200. Status: Open to the public, limited only by the space available. Purpose: The Committee is charged with providing advice and guidance to the Secretary, HHS; the Assistant Secretary for Health, HHS; the Director, CDC; and the Director, National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), regarding: (1) The practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 Name of Committee: National Cancer Institute Special Emphasis Panel; Systems for Biomarker Research and Development. Date: November 23, 2009. Time: 11 a.m. to 1 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Suite 703, Room 7142, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Thomas M. Vollberg, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7142, Bethesda, MD 20892, 301–594–9582, vollbert@mail.nih.gov. E:\FR\FM\28OCN1.SGM 28OCN1

Agencies

[Federal Register Volume 74, Number 207 (Wednesday, October 28, 2009)]
[Notices]
[Page 55567]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25913]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee, 
(HICPAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Times and Dates: 9 a.m.-5 p.m., November 12, 2009. 9 a.m.-12 
p.m., November 13, 2009.

    Place: Washington Marriott at Metro Center, Salons C-D, 775 12th 
Street, NW., Washington, DC 20005, Telephone: (202) 737-2200.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, HHS; the Assistant Secretary for Health, 
HHS; the Director, CDC; and the Director, National Center for 
Preparedness, Detection, and Control of Infectious Diseases 
(NCPDCID), regarding: (1) The practice of hospital infection 
control; (2) strategies for surveillance, prevention, and control of 
infections (e.g., nosocomial infections), antimicrobial resistance, 
and related events in settings where healthcare is provided; and (3) 
periodic updating of guidelines and other policy statements 
regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters To Be Discussed: The agenda will include updates on 
Recovery Act activities and the draft guideline for prevention of 
intravascular catheter-related bloodstream infections, and 
discussion of infection control in ambulatory care settings.
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Michelle King, HICPAC, 
Division of Healthcare Quality Promotion, NCPDCID, CDC, l600 Clifton 
Road, NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 
639-2936.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: October 20, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.

[FR Doc. E9-25913 Filed 10-27-09; 8:45 am]
BILLING CODE 4163-18-P